TY - JOUR
T1 - Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report
AU - Costamagna, Guido
AU - Giuliante, Felice
AU - Clemente, Gennaro
AU - Deodato, Francesco
AU - Mattiucci, Gian Carlo
AU - Valentini, Vincenzo
AU - Macchia, Gabriella
AU - Morganti, Alessio Giuseppe
AU - Mutignani, Massimiliano
AU - Smaniotto, Daniela
AU - Sallustio, Giuseppina
AU - Nuzzo, Gennaro
AU - Cellini, Numa
PY - 2005
Y1 - 2005
N2 - A 46-year-old female patient, with mild cholestasis by a large papillary cholangiocarcinoma involving the left hepatic duct, received intralummal brachytherapy (50 Gy at 1 cm from the source axis) with the aim to relieve biliary obstruction without stent positioning. The patient presented with haemobilia and vegetant lesions in the left main biliary duct, and thus she had a high risk of early stent obstruction. Eighteen months after the treatment the patient presented tumour progression in the controlateral hepatic lobe, but had a patent left hepatic duct, without signs of cholestasis and/or cholangitis.
Based on this and other published reports, intraluminal brachytherapy may be tested in a setting different from standard setting with the aim to safely palliate jaundice in patients with intraductal tumour growth in the biliary tract.
AB - A 46-year-old female patient, with mild cholestasis by a large papillary cholangiocarcinoma involving the left hepatic duct, received intralummal brachytherapy (50 Gy at 1 cm from the source axis) with the aim to relieve biliary obstruction without stent positioning. The patient presented with haemobilia and vegetant lesions in the left main biliary duct, and thus she had a high risk of early stent obstruction. Eighteen months after the treatment the patient presented tumour progression in the controlateral hepatic lobe, but had a patent left hepatic duct, without signs of cholestasis and/or cholangitis.
Based on this and other published reports, intraluminal brachytherapy may be tested in a setting different from standard setting with the aim to safely palliate jaundice in patients with intraductal tumour growth in the biliary tract.
KW - Brachytherapy
KW - Cholangiocarcinoma
KW - Intrahepatic cholangiocarcinoma
KW - Intraluminal brachytherapy
KW - Papillary cholangiocarcinoma
KW - Brachytherapy
KW - Cholangiocarcinoma
KW - Intrahepatic cholangiocarcinoma
KW - Intraluminal brachytherapy
KW - Papillary cholangiocarcinoma
UR - http://hdl.handle.net/10807/14556
U2 - 10.1016/j.dld.2004.07.022
DO - 10.1016/j.dld.2004.07.022
M3 - Article
VL - 37
SP - 615
EP - 618
JO - DIGESTIVE AND LIVER DISEASE
JF - DIGESTIVE AND LIVER DISEASE
SN - 1590-8658
ER -